Molecular regulaion of BACE1 and Its function at the early onset of Alzheimer's disease

Progress in Biochemistry and Biophysics

Volumn 39, Issue 8, 2012, Pages 709-714

  Wang, Tan ^a   Sun, Xiu Lian ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

A ; Alzheimer's disease; BACE1; Biomarkers

Indexed keywords

EID: 84870939173     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2012.00217     Document Type: Review

References (44)

1. Goldgaber D, Lerman M I, McBride O W, et al. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science, 1987, 235(4791): 877-880 (Pubitemid 17019124)
2. Robakis N K, Ramakrishna N, Wolfe G, et al. Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides. Proc Natl Acad Sci USA, 1987, 84(12): 4190-4194 (Pubitemid 17090899)
3. Kang J, Lemaire H G, Unterbeck A, et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature, 1987, 325(6106): 733-736 (Pubitemid 17054046)
4. Hussain I, Powell D, Howlett D R, et al. Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol Cell Neurosci, 1999, 14(6): 419-427 (Pubitemid 30026585)
5. Sinha S, Anderson J P, Barbour R, et al. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature, 1999, 402( 6761): 537-540
6. Vassar R, Bennett B D, Babu-Khan S, et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science, 1999, 286( 5440): 735-741
7. Bodendorf U, Fischer F, Bodian D, et al. A splice variant of betasecretase deficient in the amyloidogenic processing of the amyloid precursor protein. J Biol Chem, 2001, 276( 15): 12019-12023
8. Shi X P, Chen E, Yin K C, et al. The pro domain of beta-secretase does not confer strict zymogen-like properties but does assist proper folding of the protease domain. J Biol Chem, 2001, 276 ( 13): 10366-10373
9. Hogl S, Kuhn P H, Colombo A, et al. Determination of the proteolytic cleavage sites of the amyloid precursor-like protein 2 by the proteases ADAM10, BACE1 and gamma-secretase. PLoS One, 2011, 6( 6): e21337
10. Qing H, Zhou W, Christensen M A, el al. Degradation of BACE by the ubiquitin-proteasome pathway. Faseb J, 2004, 18( 13): 1571-1573
11. Tesco G, Koh Y H, Kang E L, et al. Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity. Neuron, 2007, 54(5): 721-737 (Pubitemid 46843521)
12. Christensen M A, Zhou W, Qing H, et al. Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1. Mol Cell Biol, 2004, 24(2): 865-874 (Pubitemid 38057936)
13. Cho H J, Jin S M, Son S M, et al. Constitutive JAK2/STAT1 activation regulates endogenous BACE1 expression in neurons. Biochem Biophys Res Commun, 2009, 386( 1): 175-180
14. Cho H J, Jin S M, Youn H D, et al. Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling. Aging Cell, 2008, 7(2): 137-147 (Pubitemid 351359647)
15. Chen C H, Zhou W, Liu S, et al. Increased NF-kappaB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease. Int J Neuropsychopharmacol, 2012, 15( 1): 77-90
16. Li Y, Zhou W, Tong Y, et al. Control of APP processing and Abeta generation level by BACE1 enzymatic activity and transcription. Faseb J, 2006, 20(2): 285-292 (Pubitemid 44933176)
17. Wen Y, Yu W H, Maloney B, et al. Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing. Neuron, 2008, 57(5): 680-690 (Pubitemid 351335351)
18. Zhou W, Song W. Leaky scanning and reinitiation regulate BACE1 gene expression. Mol Cell Biol, 2006, 26( 9): 3353-3364
19. Cruts M, Dermaut B, Rademakers R, et al. Amyloid beta secretase gene (BACE) is neither mutated in nor associated with early-onset Alzheimer's disease. Neurosci Lett, 2001, 313(1-2): 105-107 (Pubitemid 32973906)
20. Sun X, Tong Y, Qing H, et al. Increased BACE1 maturation contributes to the pathogenesis of Alzheimer's disease in Down syndrome. Faseb J, 2006, 20(9):1361-1368 (Pubitemid 44943844)
21. Snowdon D A, Greiner L H, Mortimer J A, et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. Jama, 1997, 277(10): 813-817 (Pubitemid 27111317)
22. Sun X, He G, Qing H, et al. Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc Natl Acad Sci USA, 2006, 103(49): 18727-18732 (Pubitemid 44913478)
23. Schreck R, Rieber P, Baeuerle P A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. Embo J, 1991, 10(8): 2247-2258 (Pubitemid 21905698)
24. Motter R, Vigo-Pelfrey C, Kholodenko D, et al. Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol, 1995, 38( 4): 643-648
25. Blennow K, Hampel H. CSF markers for incipient Alzheimer's disease. Lancet Neurol, 2003, 2(10): 605-613 (Pubitemid 37162569)
26. Gloeckner S F, Meyne F, Wagner F, et al. Quantitative analysis of transthyretin, tau and amyloid-beta in patients with dementia. J Alzheimers Dis, 2008, 14(1): 17-25 (Pubitemid 352039015)
27. Zetterberg H, Andreasson U, Hansson O, et al. Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease. Arch Neurol, 2008, 65( 8): 1102-1107
28. Zhong Z, Ewers M, Teipel S, et al. Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment. Arch Gen Psychiatry, 2007, 64(6): 718-726 (Pubitemid 46878672)
29. Ewers M, Zhong Z, Burger K, et al. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease. Brain, 2008, 131( Pt 5): 1252-1258
30. Jiang H, Hampel H, Prvulovic D, et al. Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's disease. Mol Neurodegener, 2011, 6( 1): 69
31. Zhou J W. Recent progress in neurodegenerative disorder research in China. Sci China Life Sci, 2010, 53( 3): 348-355
32. Cong L, Jia J. Promoter polymorphisms which regulate ADAM9 transcription are protective against sporadic Alzheimer's disease. Neurobiol Aging, 2011, 32( 1): 54-62
33. Tong Z Q, Han C S, Luo W H, et al. Accumulated hippocampal formaldehyde induces age-dependent memory decline. AGE ( 2012) DOI: 10.1007/s11357-012-9388-8
34. He R Q, Lu J, Miao J Y. Formaldehyde stress. Sci China Life Sci, 2010, 53( 12): 1399-1404
35. Tong Z Q, Zhang J L, Luo W H, et al. Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia. Neurobiology of Aging, 2011, 32( 1): 31-41
36. Liu Y Y, Qiang M, Wei Y, et al. A novel molecular mechanism for nitrated a-synuclein-induced cell death. J Mol Cell Biol, 2011, 3( 4): 239-249
37. Sajjad Haider Naqvi, Tau Sajjad Haider Naqvi, Wang W S, Miao J Y, et al. Prog Biochem Biophys, 2010, 37( 11): 1195-1203
38. Zhang X H, Poo M M. Progress in neural plasticity. Sci China Life Sci, 2010, 53( 3): 322-329
39. Luo Z G. Synapse formation and remodeling. Axon guidance and neuronal migration research in China. Sci China Life Sci, 2010, 53( 3): 315-321
40. Zhang M, Zhao Z M, He L, et al. A meta-analysis of oxidative stress markers in schizophrenia. Sci China Life Sci, 2010, 53( 1): 112-124
41. Sun P, Zhang Q, Han J Y, et al. TLR4 signaling induced TLR2 expression in the process of mimic cerebral ischemia/reperfusion in vitro. Sci China Life Sci, 2010, 53( 1): 112-124
42. Wang Y Z, Xu T L. Ion channels in neuronal survival. Sci China Life Sci, 2010, 53 ( 3): 342-347
43. Luo Y F, Zhang J, Liu N Q, et al. Copper ions influence the toxicity of β-amyloid (1-42) in a concentration-dependent manner in a Caenorhabditis elegans model of Alzheimer's disease. Sci China Life Sci, 2011, 54( 6): 527-534
44. Liu L L, Sheng B Y, Gong K, et al. Prog Biochem Biophys, 2010, 37(2): 154-160